ArticleFrontiers in oncology2026

Glofitamab in the sequential treatment of relapsed/refractory B-Cell lymphoma: a single-center real-world study.

Haoran Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.